GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Itoco Inc (OTCPK:ITMC) » Definitions » Pre-Tax Income

Itoco (ITMC) Pre-Tax Income : $-2.34 Mil (TTM As of Sep. 2010)


View and export this data going back to 2009. Start your Free Trial

What is Itoco Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Itoco's pretax income for the three months ended in Sep. 2010 was $0.11 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2010 was $-2.34 Mil. Itoco's pretax margin was 1,000.00%.


Itoco Pre-Tax Income Historical Data

The historical data trend for Itoco's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itoco Pre-Tax Income Chart

Itoco Annual Data
Trend Dec08 Dec09
Pre-Tax Income
2.00 -2.39

Itoco Quarterly Data
Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.09 -1.79 -0.20 -0.47 0.11

Competitive Comparison of Itoco's Pre-Tax Income

For the Biotechnology subindustry, Itoco's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Itoco's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Itoco's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Itoco's Pre-Tax Income falls into.



Itoco Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Itoco's Pretax Income for the fiscal year that ended in Dec. 2009 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.785+-0.001+-0.608+0+-4.4408920985006E-16
=-2.39

Itoco's Pretax Income for the quarter that ended in Sep. 2010 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-0.182+0.348+-0.061+0.005+1.3877787807814E-17
=0.11

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2010 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Itoco  (OTCPK:ITMC) Pre-Tax Income Explanation

Itoco's Pretax Margin for the quarter that ended in Sep. 2010 is calculated as

Pretax Margin=Pretax Income/Revenue
=0.11/0.011
=1,000.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Itoco Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Itoco's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Itoco (ITMC) Business Description

Traded in Other Exchanges
N/A
Address
50 West Liberty Street, Suite 880, Reno, NV, USA, 89501
Itoco Inc is focused on developing and bringing biotech products to the market via co-development and joint venture arrangements with various companies. The company is currently examining various technologies that seek to control and/or identify bio-contaminants such as viruses and bacteria.